Mihai et al. investigated the effect of vericiguat, a soluble guanylate cyclase (sGC) stimulator, on N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels in patients with chronic heart failure and reduced ejection fraction. This evidence concerns the gene NPPB and congestive heart failure.